Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial

The Lancet Oncology(2022)

引用 131|浏览26
暂无评分
摘要
Amgen.
更多
查看译文
关键词
colorectal cancers,krasg12c mutation,codebreak100,single-arm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要